Several tests to help create this plan may include, in addition to a general physical exam, a neurocognitive evaluation, a quantitative electroencephalography (qEEG), a computed tomography (CT) scan and/or a brain MRI scan incorporating diffusion tensor imaging, and vision and balance assessments
Persistently high levels warrant medical investigation to identify any underlying cause
GLP-1 receptor agonists such as semaglutide (marketed under brand names Ozempic, Wegovy, and Rybelsus) and the dual GIP/GLP-1 agonist tirzepatide (marketed under brand names Mounjaro and Zepbound) are FDA-approved prescription medications for specific uses in type 2 diabetes management and, in some cases, chronic weight management
Semaglutide (Wegovy, Ozempic), Tirzepatide (Mounjaro), and Liraglutide (Saxenda), based on clinical appropriateness and pharmacy availability
The difference between 12 units and 13 units represents a 0.2mg dosing variance, which is roughly 8% of the total dose